ALEXANDRA TUCKER: Open Payments
NPI 1750168530 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 72 payments from 14 companies in 2025. Trend: 2023 $466 · 2024 $2,337 · 2025 $1,859
Food & beverage: $1,825Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $881 |
| GENZYME CORPORATION | 24 | $316 |
| ABBVIE INC. | 4 | $160 |
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| CSL Behring | 3 | $63 |
| Optinose US, Inc. | 2 | $50 |
| LEO Pharma Inc. | 2 | $38 |
| Amgen Inc. | 1 | $34 |
Products named: AIRSUPRA, DUPIXENT, RINVOQ, TEZSPIRE, SYMBICORT, Rhapsido, Xhance, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
